Herbs / Vitamins / Drugs / Supplements

CODEX, Supplements & Dianne Feinstein

As promised, here is the text of the letter Senator Feinstein sent one of my clients in response to her inquiry concerning the availability of supplements if CODEX is implemented in the U.S. I have crossed out her name and e-mail address to protect her privacy. If you are affiliated with the Democratic party and are concerned about the availability of natural health care, I recommend you contact the Senator’s office personally and express your dismay at her position. The issue regarding ephedra is a red herring, since the herb was being abused, not used. Yet, we are all being punished as a result of the actions of a few!!

“From: senator@feinstein.senate.gov Date: August 12, 2005 9:34:46 AM PDT To: Subject: U.S. Senator Dianne Feinstein responding to your message August 12, 2005 Mrs. xxxxxxxx xxxxxxxxx Pasadena, California xxxxx Dear Mrs.xxxx: Thank you for writing to me with your thoughts about regulating dietary supplements. I appreciate hearing from you and welcome this opportunity to respond. The availability of dietary supplements to the public is important, but it is equally important that these supplements do not put the consumer’s health at stake. I believe that if we are to ensure the safety of those who consume dietary supplements, we must make sure that these supplements are not hazardous to their health. We cannot allow deaths, such as those caused by the dietary supplement Ephedra, to continue. The herbal supplement Ephedra was associated with 164 deaths between 1994 and April of 2004, when it was banned by the Food and Drug Administration (FDA). Sadly, in the time between the FDA announcement of the ban in December of 2003 and the time of the ban’s implementation in April of 2004, four people died from taking Ephedra. I believe that something more must be done to ensure that dietary supplements are safe and effective. Last year, I cosponsored the ADietary Supplement Safety Act of 2003? that would require all dietary supplement manufacturers to report serious adverse experiences to the Secretary of Health and Human Services. After one or more of these reports are collected, the FDA would conduct a detailed evaluation process and investigate the occurrences. Waivers would be available for certain supplements that would not warrant such concerns. Under the bill, the FDA could only remove products from the market if it determines that the product “is not safe or has not been shown to be safe under ordinary or frequent conditions of use.” As such, unless a vitamin is shown to cause such serious adverse events, it could not be removed from the market under this bill. This bill did not pass the Senate last year, but similar legislation may come before the Senate during this Congress. Please know that I will keep your thoughts in mind. Again, thank you for writing. I appreciate knowing your views on this issue. If you have any further questions or concerns, please feel free to call my Washington, D.C. staff at (202) 224-3841.

Sincerely yours, Dianne Feinstein United States Senator http://feinstein.senate.gov

Further information about my position on issues of concern to California and the Nation are available at my website http://feinstein.senate.gov. You can also receive electronic e-mail updates by subscribing to my e-mail list at http://feinstein.senate.gov/issue.html.”

Does this apply to you? If so, see our information on Consultations.

[TOP]